Rheumatoid Arthritis Posts Page 2 on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Is certolizumab pegol an effective medication for the treatment of rheumatoid arthritis?

Posted by on Oct 30, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study reviewed data on clinical trials investigating the effects of certolizumab pegol (Cimzia) for the treatment of rheumatoid arthritis. They found that certolizumab pegol is an effective medication for the treatment of rheumatoid arthritis. Some background Rheumatoid arthritis (RA) is an autoimmune disease that causes...

Read More

Does baricitinib improve patient reported outcomes in the treatment of rheumatoid arthritis?

Posted by on Oct 30, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the patient reported outcomes (PRO) in patients receiving baricitinib (Olumiant) and methotrexate (Trexall). They found that patients receiving baricitinib had greater improvement in PRO compared to methotrexate alone. Some background Rheumatoid arthritis (RA) is an autoimmune disease where the...

Read More

Biological treatments do not increase cancer risk in rheumatoid arthritis

Posted by on Oct 23, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if there is an increased risk of cancer in rheumatoid arthritis patients taking immunomodulating drugs. They found that there was no increased cancer risk in patients taking biological DMARDs compared to conventional synthetic DMARDs. Some background Rheumatoid arthritis (RA) is a chronic inflammatory...

Read More

Are disease-modifying anti-rheumatic drugs (DMARDs) a safe, long-term treatment for rheumatoid arthritis?

Posted by on Oct 18, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study analyzed the safety of disease-modifying anti-rheumatic drugs (DMARDs) for the treatment of rheumatoid arthritis (RA). They found that patients taking biological DMARDs had a higher risk of infections compared to synthetic DMARDs. Some background Rheumatoid arthritis (RA) is an auto-immune condition which causes...

Read More

Thromboembolism risk in patients with inflammatory conditions including rheumatoid arthritis

Posted by on Oct 3, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if there was a risk of thromboembolism (blood clots) in patients with rheumatoid arthritis, psoriasis or psoriatic arthritis. They found that patients with rheumatoid arthritis had a greater risk of thromboembolism. Some background Rheumatoid arthritis (RA) is a condition that causes pain and inflammation in...

Read More

Does delayed anti-TNF therapy increase the risk of total knee replacement in patients with rheumatoid arthritis?

Posted by on Sep 27, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if the timing of anti-tumor necrosis factor (TNF) therapy affected rates of knee replacement in patients with rheumatoid arthritis. They found that early intervention with anti-TNF therapy reduced the risk of total knee replacement (TKR) surgery. Some background Rheumatoid arthritis (RA) is a condition where...

Read More

Can Video Gaming Build Resilience? You Decide…

Can Video Gaming Build Resilience?   You Decide…

Posted by on Sep 20, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke | 0 comments

In the aftermath of Hurricanes Harvey and Irma, a recent news story discussed the mental health consequences of disasters. Researcher Jean Rhodes of University of Massachusetts Boston studied the mental health of young parents living in New Orleans before and after Hurricane Katrina. RISK- Resilience In Survivors of Katrina is the project’s name. An...

Read More

Is tocilizumab a safe and effective treatment for early rheumatoid arthritis?

Posted by on Sep 10, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if tocilizumab (Actemra) monotherapy or combination therapy with methotrexate (Trexall) was safe and effective in the long-term for treating patients with early rheumatoid arthritis (RA). They found that the tocilizumab alone (monotherapy) and in combination with methotrexate was safe and effective at 2...

Read More

Can low disease activity be maintained in early rheumatoid arthritis without adalimumab?

Posted by on Sep 10, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if low disease activity could be maintained in early rheumatoid arthritis following discontinuation of long-term adalimumab. They found that the majority of patients that discontinued adalimumab maintained low disease activity after 3 years. Some background Rheumatoid arthritis is an autoimmune disease...

Read More